LABORATORY RESEARCH AGE Modified Basement Membrane Cooperates with Endo180 to Promote Epithelial Cell Invasiveness and Decrease Prostate Cancer Survival Scientists hypothesized that the structural alterations in the basal lamina associated with age can induce mechanotransduction pathways in prostate epithelial cells to promote invasiveness and cancer progression. [J Pathol] Abstract MicroRNA-940 Suppresses Prostate Cancer Migration and Invasion by Regulating MIEN1 A novel microRNA (miRNA), hsa-miR-940 (miR-940), identified and validated to be highly expressed in immortalized normal cells compared to cancer cells, is a regulator of migration and invasion enhancer 1 (MIEN1). Analysis of human prostate tumors and their matched normal tissues confirmed that miR-940 is highly expressed in the normal tissues compared to its low to negligible expression in the tumors. [Mol Cancer] Abstract | Full Article Combination Simvastatin and Metformin Induces G1-Phase Cell Cycle Arrest and Ripk1- and Ripk3-Dependent Necrosis in C4-2B Osseous Metastatic Castration-Resistant Prostate Cancer Cells Treatment of C4-2B cells with combination 4μM simvastatin and 2mM metformin led to significant G1-phase cell cycle arrest and decrease in the percentage of DNA-replicating cells in the S-phase by 24 hours; arrest was sustained throughout the 96-hour treatment. [Cell Death Dis] Full Article Apigenin Manipulates the Ubiquitin-Proteasome System to Rescue Estrogen Receptor-β from Degradation and Induce Apoptosis in Prostate Cancer Cells Researchers investigated apigenin, a dietary flavonoid with proteasome-inhibitory activity, against FDA-approved anticancer proteasome inhibitor bortezomib in context to its effects on the tumor suppressor estrogen receptor-beta in prostate cancer cells. [Eur J Nutr] Abstract The Cytotoxic and Pro-Apoptotic Activities of the Novel Fluoropyrimidine F10 towards Prostate Cancer Cells Are Enhanced by Zn2+-Chelation and Inhibiting the Serine Protease Omi/HtrA2 To test the hypothesis that the pro-apoptotic effects of F10 could be enhanced by modulating intracellular Zn2+ scientists investigated cell-permeable and cell-impermeable Zn2+ chelators and exogenous Zn2+ and evaluated cell viability and apoptosis in cellular models of castration-resistant prostate cancer. [Prostate] Abstract Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior To improve the adherence of LNCaP cells to the culture surface, researchers compared different coating reagents and culturing conditions and analyzed their impact on cell proliferation, adhesion, morphology, mobility and gene expression using real-time technologies. [PLoS One] Full Article Comprehensive Study of Gene and MicroRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer Scientists analyzed gene and microRNA expression involved in epithelial-mesenchymal transition in localized prostate cancer and metastatic prostate cancer cell lines and correlate with clinicopathological findings. They studied 51 fresh frozen tissue samples from patients with localized prostate cancer treated by radical prostatectomy and three metastatic prostate cancer cell lines. [PLoS One] Full Article NSK-01105 Inhibits Proliferation and Induces Apoptosis of Prostate Cancer Cells by Blocking the Raf/MEK/ERK and PI3K/Akt/mTOR Signal Pathways Researchers investigated the antitumor activities of NSK-01105, a novel sorafenib derivative, in in vitro and in vivo models, and explored the potential mechanisms. [Tumor Biol] Abstract Antiproliferative Activity of Aqueous Leaf Extract of Annona muricata L. on the Prostate, BPH-1 Cells, and Some Target Genes Annona muricata L. has been reported to possess antitumor and antiproliferative properties. Scientists determined the effect of A. muricata on human BPH-1 cells and prostate organ. [Integr Cancer Ther] Abstract CLINICAL RESEARCH A Phase I Study of TRC105 Anti-CD105 (Endoglin) Antibody in Metastatic Castration-Resistant Prostate Cancer Scientists evaluated the safety, pharmacokinetics, and pharmacodynamics of TRC105 in patients with metastatic castration-resistant prostate cancer. [BJU Int] Abstract Evaluation of PSF1 as a Prognostic Biomarker for Prostate Cancer Scientists evaluated the relationship between partner of SLD5 1 (PSF1) expression and the clinical features of prostate cancer. They show that the PSF1 expression correlated significantly with PSA values at diagnosis, with tumor grade, and with clinical stage. [Prostate Cancer Prostatic Dis] Abstract |